Perception Neuroscience's PCN-101 (R-Ketamine) Demonstrates Tolerability in Phase 1 Single Ascending Dose Study - BioSpace

Submitted by Anonymous (not verified) on Fri, 02/19/2021 - 17:01

Perception Neuroscience's PCN-101 (R-Ketamine) Demonstrates Tolerability in Phase 1 Single Ascending Dose Study  BioSpace